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The bicuspid aortic valve is a common congenital heart disease characterised
by inequality of cusp size, a central raphe, and smooth cusp margins even in
diseased valves. It may progress and become calcified, leading to varying de-
grees of aortic valve disorders, such as stenosis, regurgitation, or combined,
which may eventually necessitate surgical intervention. The bicuspid aortic valve
is not a disorder confined to the aortic valve, but a spectrum involving the
aortic valve, aortic annulus, aortic root, ascending aorta, and the left ventricu-
lar outflow tract. Different types of bicuspid aortic valves may present with
distinct aetiologies and morphologies. The anatomopathological features of
the bicuspid aortic valve have not been sufficiently elucidated. Differences in
the anatomy of the bicuspid aortic valve could reflect different pathogeneses
and different needs for different therapeutic approaches. Debates still remain
in terms of timing of surgery and surgical indications of this disorder. The aim
of the present article is to make a review of the anatomy and the management
strategies of the bicuspid aortic valve in order to draw inferences about the
clinical implications. (Folia Morphol 2011; 70, 4: 217–227)
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INTRODUCTION
The bicuspid aortic valve (BAV) is a common con-
genital heart disease characterised by inequality of
cusp sizes, a central raphe, and smooth cusp mar-
gins even in diseased valves [96]. Most patients
with a BAV are unaware of the diagnosis until they
become symptomatic or the onset of infective en-
docarditis, or when they are subject to an inciden-
tal echocardiographic examination [4]. BAV is of-
ten associated with aortic dilation, aneurysms, and
dissection, which can be the main problems of BAV.
However, the pathogenesis is still unknown. More-
over, the implications of the anatomopathology of
BAV in the development of the aortic disorders that
constitute a special entity along with BAV have not
been elucidated. The present article aims to present




BAV represented 6–22% of the patients for na-
tive aortic valve surgery [66, 95]. Sabet et al. [75]
reported a large patient population with diseased
BAV, aging from 1 to 86 years with a mean age of
61 years, showing a strong male predominance. Simi-
larly, Yotsumoto et al. [102] reported a group of 63
BAV patients with a mean age of 53 years ranging
from 14 to 76 years. It has been reported that BAV
patients with aortic regurgitation were significantly
younger than those with aortic stenosis (45 ± 13 vs
60 ± 11 years, p < 0.01). Ichihara et al. [39] and
Koide et al. [50] observed the same results with re-
spect to patients’ age with stenotic or regurgitant
BAVs. Aortic regurgitation in BAV showed stronger
male gender predominance than aortic stenosis [39].
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When comparing to the patients with tricuspid aortic
valve disorder, stenotic BAV patients were 7.1 years
older, and the regurgitant BAV patients were
6.3 years younger at the time of aortic valve repla-
cement [50]. The prevalence of BAV in patients with
Marfan syndrome was 4.5%; the concurrence of both
conditions would lead to more aggressive aortic dis-
order at an earlier stage [2].
Classifications
In 1983, Brandenburg et al. [12] suggested, on
the basis of two-dimensional echocardiography,
a classification system of BAV according to the fused
leaflet and the position of the raphe, which has now
been popularly accepted in clinical practice: type 1,
fusion of right and left coronary cusp (R-L); type 2,
right and non-coronary fusion (R-N); and type 3, left
and non-coronary fusion (L-N) (Fig. 1). Clinical obser-
vations revealed that type 1 was the most frequent
BAV, accounting for 70–79.6% of cases [34, 78], fol-
lowed by type 2, at 20.4%, and type 3 was the least
with only 0.5%. Subsequently, several new classifica-
tion schemes were readily suggested in order to in-
volve more information of the status of BAVs.
Sadee et al. [76] divided BAVs into 3 types: valves
that were purely bicuspid (23%), bicuspid valves with
a raphe (34%), and valves with an additional inden-
tation of the free edge of the conjoined cusp (43%).
Tokunaga et al. [92] categorised BAV into four types:
Type I (44.7%) in which 2 cusps are situated right
and left, a coronary artery arises from each related
sinus of Valsalva; Type II (22.4%) which is Type I + ra-
phe in the right cusp; Type III (3.5%) which has one
anterior cusp and one posterior cusp with both coro-
nary arteries arising from the anterior cusp; and Type IV
(29.4%) which is Type III + raphe in the anterior cusp.
Regarding preoperative diagnosis, aortic stenosis
dominated in Type I (78.8%) and aortic regurgita-
tion dominated in Type IV (72.0%). Implanted valve
sizes were 22.2 ± 1.8 (Type I), 23.4 ± 1.6 (Type II),
and 24.0 ± 2.2 mm (Type IV), and a significant dif-
ference was noted between Type I and Type II, as
well as between Type I and Type IV. Recently, a new
classification was proposed by Sievers and Schmidt-
ke [82] on the basis of number of raphae, spatial
position of cusps or raphae, and functional status of
the valve. Three major types were identified accord-
ing to the number of raphae: type 0 (no raphe), type 1
(one raphe), and type 2 (two raphae) (Fig. 2), fol-
lowed by two supplementary characteristics: spatial
position and function. Similar BAV phenotypes were
defined by the presence and orientation of cusps and
raphae in cardiovascular magnetic resonance (CMR)
as: (1) Two well-developed cusps and commissures
without a raphe; (2) A malformed commissure, and
a raphe extending from the commissure to the free
edge of the two underdeveloped conjoint cusps [15].
Moreover, Sonoda et al. [85] divided BAVs into an-
teroposteriorly (A-P) located, and right-left (R-L) lo-
cated BAVs.
In humans, most BAVs result from fusion of ei-
ther the right-coronary and left-coronary leaflets
(R-L) or the right-coronary and non-coronary leaflet
(R-N). R-N BAV can be associated with a greater de-
gree of valve dysfunction [33, 74, 77]. Compared to
the R-N type, the R-L type BAV was associated a more
diseased aortic wall, at younger age, and with a larg-
er aortic root. Cystic medial necrosis of the ascend-
ing aortic wall was particularly prevalent in patients
with BAV of an R-L type [16].
Studies in animal models have suggested distinct
aetiologies regarding different subtypes: R-N BAVs
result from defective development of the cardiac
endocardial cushions, whereas R-L BAVs result from
an extra fusion of the septal and parietal ridges [35].
BAVs in Gata5–/– mice were the result of a fusion
between the posterior intercalated cushion and the
septal ridge, resulting in an R-N subtype [54]. Clini-
cal observations revealed that patients with R-L BAV
had larger aortic annulus and ascending root dimen-
sions compared to those with R-N BAV [45]. The R-N
BAVs have been suggested as a morphogenetic
defect formed before the cardiac outflow tract septa-
Figure 1. Brandenburg classification of bicuspid aortic valve.
Figure 2. Sievers and Schmidtke classification of bicuspid aortic
valve.
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tion and probably an exacerbated nitric oxide-de-
pendent epithelial-to-mesenchymal transformation
product. The R-L BAVs may result from the anoma-
lous septation of the proximal portion of the car-
diac outflow tract caused by distorted behaviour of
neural crest cells. Discrepancies between the R-N
and R-L BAVs may rely on the relationship between
the BAV morphologic phenotypes and other heart
diseases [35]. Interestingly, differences in aortic
elasticity among different BAV phenotypes have
been noted. Patients with an R-N type BAV had in-
creased aortic stiffness at the sinuses of Valsalva
compared with the R-L type BAV, but no difference
was found in stiffness between the ascending aor-
ta and aortic arch [79].
Aortic stenosis and regurgitation
BAV is the cause of aortic stenosis in 70–85% of
paediatric patients and about 50% of adult patients.
Indications for aortic valve replacement in BAV pa-
tients are the same as rheumatic or senile degener-
ative aortic valve disorders; however, BAVs often
extend the lesions from the valve leaflets to the left
ventricular outflow tract and even the ascending
aorta. Furthermore, BAVs are usually associated with
several congenital anomalies, infective endocardi-
tis, and acute aortic aneurysm or dissection [14].
Aortic stenosis may become the cause of the prima-
ry cardiac events in children with BAV; however, it is
usually amenable to balloon dilation [56].
Nistri et al. [63] demonstrated that the ascend-
ing aortas of BAV patients with aortic regurgitation
were less stiff and more distensible compared to
those of individuals with normally functioning BAVs.
A BAV may progress and become calcified, leading
to varying degrees of severity of aortic stenosis and
aortic regurgitation, which may eventually necessi-
tate surgical intervention [11]. There have been di-
verse proportions of valvular abnormalities and nor-
mally functioning valves among patient populations
of BAV from different centres. In 280 adult patients
with isolated BAV, echocardiography analysis
showed that BAVs were normally functioning in
39%, stenotic in 33%, and regurgitant in 27% [27].
Sabet et al. [75] reported 75% of the diseased BAVs
were purely stenotic, 13% purely regurgitant, 10%
combined stenotic and regurgitant, and 1% normally
functioning. Luciani et al. [55] described 11% of BAVs
as being stenotic; 65% as regurgitant, and 24% as
mixed lesions.
Moderate or severe aortic stenosis was most
common, and moderate or severe aortic regurgi-
tation was more frequently observed in patients
with type 2 BAV. Most aortic coarctation patients
(89%) had type 1 BAVs, with lesser degrees of
valve stenosis or regurgitation [78]. Aortic regur-
gitation was more severe in A-P type than in R-L
type BAVs, while aortic stenosis was more severe
in the R-L type than in the A-P type. The area ec-
centricity index (the ratio of the larger aortic cusp
area to the smaller aortic cusp area) was larger in
raphe type than in non-raphe type (1.83 ± 0.53
vs 1.51 ± 0.47, p < 0.05) [85].
The raphae
A raphe is a typical sign of diagnosing a BAV [100].
It may appear in 50–76% of patients, with 67% typi-
cal and 9% atypical [53, 73, 75]. When the cusps
were R-L located, the false commissures were always
in the right cusp; when the cusps were A-P located,
the raphe was always in the anterior cusp [73]. Raphe
position was between the right and left cusps in 86%
and raphe absence occurred more often in valves with
equal-sized cusps than unequal [75]. Kuboki [53]
noted that the raphe was more frequently seen in
BAVs with mixed aortic stenosis and regurgitation
and those without aortic stenosis or regurgitation
than in those with pure aortic stenosis, and all cases
had raphae in BAVs without aortic stenosis or regur-
gitation. Yotsumoto et al. [102] noted that 55% of
BAVs with a raphe had aortic regurgitation, and 76%
of BAVs without a raphe had aortic stenosis. Patients
with a BAV with a raphe were significantly younger
than those without a raphe at the time of surgery
(50 ± 15 vs 57 ± 11 years, p = 0.02). A study on
cusp weight showed that the raphe and non-raphe
cusps differed in weight in 74% of patients, with the
raphe cusps being larger in 74% of patients, and simi-
lar weights were noted in 26% of patients. Of the
patients with raphae in neither cusp, 82% of cusps
differed in weight and 18% had similar weights [73].
Diverse hypothesis existed in the pathological
changes of the raphe of BAVs. In the raphe group,
infective endocarditis, prolapse of the aortic valve,
and cusp thickening with contraction were the caus-
es of aortic regurgitation. In the non-raphe group,
infective endocarditis, and cusp contraction in
younger patients, were the causes of aortic regurgi-
tation. The reduced tendency towards calcium dep-
osition in raphed BAV can be an important factor
leading to pure aortic regurgitation [100]. How-
ever, some authors suggested that the raphe should
be the main location of calcification because spi-
ralled collagen fibrils were observed [91].
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The annulus
Observations of the aortic annulus in BAV pa-
tients generated different results. Ichihara et al. [39]
reported that the annular diameter measured dur-
ing surgery was significantly narrower in the BAV
patients compared to patients with a tricuspid aor-
tic valve undergoing aortic valve replacement dur-
ing the same period. Annular dilation was associa-
ted with aortic regurgitation to a greater degree
than aortic stenosis (48% vs 11%, p < 0.001). Os-
aka et al. [66] did not find any significant differ-
ence in the aortic annular size between BAV and
non-BAV patients by preoperative echocardio-
graphy (22.8 ± 2.0 vs 22.5 ± 2.2 mm in aortic
stenosis, and 25.4 ± 2.4 vs 23.4 ± 2.5 mm in aor-
tic regurgitation). In comparison to the stenotic
tricuspid aortic valve, a stenotic BAV often had
a smaller diameter of preoperative valve orifice
(6.9 vs 9.2 mm, p < 0.05), and a smaller valve ring
diameter (23.0 vs 24.3 mm, p < 0.05), but the valve
prostheses used for the patients in the operations
had almost identical sizes of 22 mm [50]. A supra-
annular type prosthetic valve was more frequently
inserted in BAV than in tricuspid aortic valve pa-
tients because the BAV annulus can cause difficul-
ty in prosthetic insertion [69]. However, of the BAVs,
the aortic annulus diameter was often larger in the
A-P type than in the R-L type (15 ± 3 vs 13 ± 2 mm/
/body surface area, p < 0.05) [85]. A few patients
with a regurgitant BAV had annuloaortic ectasia, which
was suspected as an underlying cause of solitary
aortic regurgitation [3].
Cusp calcification
BAV calcification was the most common cause
of pure aortic stenosis, representing 38% of valve
replacements, followed by degenerative calcification
of tricuspid aortic valves (33%), and postinflamma-
tory (presumably rheumatic) calcification and fibro-
sis (24%) [68]. Moderate to severe calcification af-
fected valves with aortic stenosis more frequently
than aortic regurgitation [75]. The calcification can
be seen in 3 different locations: cusp bases (base
type), free edges (edge type), and both bases and
edges (mixed type). Among 10 patients with
a stenotic BAV, 10% had a base type and 90% had
a mixed type calcification, while 23.1% had an edge
type and 76.9% had a mixed type in patients with
rheumatic aortic stenosis [99]. The cusps of BAVs
were the most severely thickened compared to se-
nile and rheumatic aortic stenosis. Among 324 pa-
tients younger than 70 years of age, calcified BAVs
were observed in 50%. In contrast, among those
aged 70 years or older, degenerative calcification
accounted for 48% of the stenotic aortic valves [68].
By echocardiography, aortic valve sclerosis began
from the second decade, and the sclerotic index pro-
gressed with age, while aortic valve calcium was
noted from the fourth decade [8].
Calcification was severe in patients with a stenotic
BAV or a stenotic predominance of mixed valve steno-
sis and regurgitation; however, calcification was lim-
ited in cases with regurgitant dominancy in a mixed
valve disorder. Therefore, BAV did not necessarily
become stenotic, and this has been confirmed by the
normally-functioning cases with no stenosis or re-
gurgitation. Cases without a raphe were prone to be
markedly calcified and stenotic, and cases with
a raphe were not [53]. In the patients with pure aortic
stenosis, calcified BAVs accounted for 46%, and ac-
counted for 19% for combined aortic stenosis and
insufficiency [86]. Calcification in BAV was more fre-
quently found in the A-P cusps than in the R-L cusps,
suggesting that calcification may result in aortic
stenosis [64].
The distribution of calcium was more diffuse
throughout the body of calcified BAVs; while cal-
cific deposits of calcified tricuspid aortic leaflets
are typically superimposed in nodular form. That
is why BAVs can hardly be amenable to operative
or percutaneous valvuloplasty [42]. Pathological
findings of the pure regurgitant valves revealed
neither calcium deposit nor findings of infection,
but commonly showed myxoid degeneration [3].
Histological study of the excised valves disclosed
severe myxoid degeneration in 16 of 27 patients
with aortic regurgitation [102]. In stenotic BAVs,
the pathological findings of the resected valve in-
cluded irregular fibrotic thickening and marked
calcification without any vegetation or thrombus
formation [101]. Grossly, the cusps were thickened,
rolled, and redundant; microscopically, they con-
sisted of immature loose connective tissue consis-
tent with a dysplastic or incompletely differentiat-
ed valve [19]. In rheumatic aortic valve disorder,
microfibril-like fibrillar structures were found in the
areas of deposition of electron-dense materials,
suggesting degradation and necrosis of newly
formed connective tissue because of nutritional
deprivation, especially in the thickened central area,
leading to calcium deposition. In contrast, in de-
generative and BAV, numerous lipid vacuoles were
found in the electron-dense deposition areas simi-
lar to lipid deposition in aortic atherosclerosis. The
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increase of the haemodynamic load with abnormal
structure in BAVs may be prone to the sclerotic
changes with the degeneration of collagen fibres,
providing a core for calcification [91].
Aortic valve pressure gradient increased approxi-
mately 18 mm Hg each decade, concomitant with
progression of valve sclerosis. Progression of cusp
sclerosis was faster in patients with A-P located cusps
than in those with R-L located cusps, and was faster
in those with eccentric cusps than in those with sym-
metric cusps. In patients with eccentric and A-P lo-
cated cusps, aortic valve pressure gradient increased
27 mm Hg per decade [8].
Fibrous bands
The fibrous band was present in 6% of BAVs,
where the raphe was fenestrated with only a thin
fibrous band (or bands) joining the valve cusp to
the aortic wall (type A); or a similar fibrous band (or
bands) associated with other usually appearing
raphal tissue (type B) [102]. An observation of BAV
leaflets revealed neither calcium deposit nor infec-
tion but did show collagenous fibrous tissue with
focal mucinous degeneration [3]. The majority of
BAVs with an abnormal fibrous band stretched from
the centre of the conjoined cusp to the aortic wall
were found in the patients with aortic regurgita-
tion. But in extreme cases, it was associated with
aortic stenosis [61]. A degenerative change alone
was evidenced by histology in the resected fibrous
band, which was supposed to be an embryogenic
remnant of the aortic valve [59].
Aortic root
Aortic stenosis and aortic regurgitation were
equally common in tricuspid aortic valve and BAV with
normal aortic dimensions, while aortic regurgitation
was predominant in tricuspid aortic valve with dilat-
ed aortas, and aortic stenosis was predominant in
BAV with dilated aortas. Aortic dilation was evenly
distributed in BAV regardless of leaflet morphology
[43]. Not all patients with BAV, but the patients with
an elevated 10-year risk of > 7%, tobacco use, and
higher random blood glucose level, demonstrated
progressive aortic dilation [41]. Aortic root dilation
has been documented in childhood, suggesting that
this process begins early in life [84]. Although mild
ascending aortic dilation was common in children,
the clinical course was relatively benign [56].
In the worst case of BAV, this aortopathy can
result in rupture or dissection [83]. Aortic dissec-
tion can occur at dimensions < 5 cm in both BAV
patients and the general population [67]. But the
mean diameter of the ascending aorta progress-
ing to dissection in the setting of BAV was 6 cm
[89]. Some have advocated earlier repair of as-
cending aorta at 5 cm [87]. Root replacement is
commonly recommended for Marfan syndrome
when the aorta is £ 4.5 cm [48]. If the cause is
related to pathological valvular haemodynamics,
the correction of the valvular disease would theo-
retically also ameliorate the aortopathy, render-
ing aortic replacement less necessary. If the cause
is related to genes, the replacement of the dilat-
ed aorta will be performed more liberally to stop
the haemodynamically independent process of
dilation and, thus, to reduce the risk for rupture
or dissection [83].
AETIOLOGY
A haemodynamic origin of the BAV phenotypes
was advocated [37]. BAVs have currently been evi-
denced to be heritable, and BAV can be malformed
in the condition of defective valvulogenesis [22].
Patients with BAV have thinner elastic lamellae of
the aortic media and greater distances between elas-
tic lamellae than patients with tricuspid aortic valves
[44]. Echocardiographic studies showed that BAVs
had significantly lower aortic distensibility and great-
er aortic stiffness index in comparison with the con-
trols [9]. Histologically, the ascending aorta can
present cystic medial necrosis and elastic fragmen-
tation, similar to Marfan syndrome [26]. In aneu-
rysm tissue from patients with BAV, Nataatmadja
et al. [62] discovered intracellular accumulation and
reduction of extracellular distribution of fibrillin, fi-
bronectin, and tenascin to a similar degree as that
found in patients with Marfan syndrome. Nistri et
al. [63] performed a similar study and found that
42% of the BAV patients had impaired aortic elas-
ticity. Dysregulation of fibrillin-1 during valvulogen-
esis may lead to poor development of the aortic
cusps, resulting in a BAV and a weakened aortic root
[32]. Reduced fibrillin-1 content in both ascending
aorta and pulmonary trunk are possible causes of
the weakness of the aortic wall [26]. Type I and III
collagens were significantly decreased in the dilat-
ed aortas in the BAV patients compared to the con-
trols [21]. The endothelial nitric oxide synthase ex-
pression of aortic endothelial cells was significantly
lower in patients with a BAV as compared to tricus-
pid aortic valves (4,615 ± 489 vs 6,275 ± 442,
p = 0.017) [1]. In BAVs, there was a significant cor-
relation between endothelial nitric oxide synthase
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expression and maximal aortic diameter or sinotu-
bular diameter, whereas in patients with tricuspid
aortic valves no significant correlation between aor-
tic size and endothelial nitric oxide synthase expres-
sion was found [1].
The initial stages of valve formation involve mul-
tiple signalling molecules including members of the
TGF-b, Ras, Wnt/b-catenin, vascular endothelial
growth factor, and NOTCH signalling families [57].
By mouse genetics, determination of the function of
Gata5 in mammalian embryogenesis was made, and
it was shown that deletion of Gata5 may result in
BAV formation [54]. The Lrp5/Wnt/b-catenin pathway
plays an important role in the development of vascu-
lar and valvular calcification [18]. The Wnt/Lrp5/friz-
zled complex turns on downstream components such
as dishevelled Dvl/Dsh, which leads to repression of
the glycogen synthase kinase-3 (GSK3) [38]. BAV cov-
ers a spectrum of diseases from early atherosclerotic
changes in the valve leaflets; aortic sclerosis, which is
characterised by early calcification and thickening;
and, finally, to outflow obstruction and severe aortic
stenosis [72].
Alpha1-antitrypsin may play an important role in
maintaining the integrity of connective tissue, in-
cluding the blood vessel wall. Aneurysmal patho-
genesis appears to be complex, and several investi-
gators have tried to find a connection between
a1-antitrypsin deficiency and formation of abdominal
aortic aneurysms. Kilickesmez et al. [47] noted that
the plasma a1-antitrypsin concentration was nega-
tively correlated with dilation of the ascending aor-
ta in patients with BAV, indicating that the serum
a1-antitrypsin concentration remains a possible
biomarker of aortic aneurysm growth.
BAV aneurysms have increased apoptosis, great-
er degrees of elastic fragmentation, and alterations
in tissue concentrations of matrix metalloproteinase
(MMP) and endogenous inhibitors [40]. Elevation in
MMP-2 expression was found in BAV aortic aneu-
rysms, while the level of MMP-9 activity was normal
[13]. MMP-2/TIMP-1 in ascending aorta was greater
in BAV and aortic dilation patients [98]. Immunohis-
tochemical studies demonstrated evidence of intrac-
ellular accumulation of fibrillin, fibronectin, and ten-
ascin, increased expression of increased levels of MMP-2,
and in vitro evidence of increased smooth muscle cell
apoptosis among BAV-associated aneurysms [62].
DIAGNOSIS
Two-dimensional echocardiography may pro-
vide accurate configuration of a BAV, and has been
taken as a golden standard for the diagnosis of
BAV as well as severity of the morphology of the
aortic valve and the ascending aorta. The short-
axis view is used to examine commissures, leaflet
morphology, mobility, and the presence or ab-
sence of a low raphe. Therefore, the diagnosis of
a BAV is based on the clear demonstration of two
cups and two commissures in systole and diasto-
le in the short-axis view. However, the short-axis
view in some cases may present as almost normal
because of a fused raphe in the middle of one of
the two leaflets. Moreover, BAV may show a dom-
ing configuration in the long-axis view during sys-
tole [71]. However, a false positive diagnosis may
result from an unclear follow-up [36]. The sensi-
tivity, specificity, positive predictive value, and
negative predictive value for the detection of
a BAV were 76.5%, 60.6%, 68.4%, and 95.2%,
respectively, for echocardiography and 94.1%,
100%, 100%, and 97.1%, respectively, for com-
puted tomography. The computed tomographic
findings were not significantly different from the
intraoperative findings, but the echocardiographic
findings were [90]. Both cardiac computed tomog-
raphy and MRI now offer a valuable adjunct for
accurate diagnosis of BAV. The absence of three
cusps forming a ”Y” configuration of the tricus-
pid aortic valve is suggestive of the diagnosis of
a BAV [81]. Multi-detector computed tomographic
(MDCT) features of uneven cusp size, round-
shaped opening, midline calcification, longer leaf-
let fusion, and larger diameter of the ascending
aorta can be helpful in distinguishing BAVs from
tricuspid aortic valves [46].
TREATMENT AND PROGNOSIS
Beta-blockers may improve the haemodynamics
of the patients in a state of heart failure. The use of
b-blockers in BAV patients may retard aortic root di-
lation and prevent aortic valve regurgitation, and may
be reasonable in those with aortic root dilation to
retard further progression and also reduce the risk of
aortic dissection [28]. Aortic valve infective endocardi-
tis complicated by valvular dysfunction may indicate
the need for a combination of aggressive antimicro-
bial therapy and early surgery [52].
The current surgical strategies including ACC/AHA
support more aggressive treatment of BAV-related
aortic dilation at smaller aortic size [20]. Valve-spar-
ing aortic root replacement provides durable results
in tricuspid and bicuspid valve anatomies. Symmet-
ric tricuspidisation of the valve was thus achieved [51].
223
S.-M. Yuan, Bicuspid aortic valve
The timing of surgery and procedures contin-
ues to be debated, with some authors advocating
surgery at an aortic size > 5.5 cm and others sug-
gesting surgery at < 4.5 cm. A regurgitant BAV
should be repaired, and the aorta should be re-
placed when the ascending aorta is significantly
dilated at > 4.5 cm or aortic cross-sectional area/
/height ratio > 10 cm2/m [88]. Dayan et al. [24] sug-
gest that aortic valve replacement prevents aortic
root dilation in BAV patients whose aortic root dia-
meter at the time of surgery was £ 4.5 cm. Boodh-
wani et al. [10] reported that all their BAV patients
underwent supracoronary ascending aortic replace-
ment and sinotubular junction remodelling with
a Dacron prosthesis. If the raphe was fibrous, with-
out significant calcification, it was simply shaved
and the leaflet was left intact. If the raphe was cal-
cified or severely restrictive, it was resected. Wald
et al. [94] proposed that aorta replacement should
be considered when aortic dilation with a size of
(1) > 4.0 cm in patients with concomitant aortic
valve replacement or other heart operations;
(2) > 4.5 cm with rapid dilation of 0.5 cm/year, or
aortic coarctation, first-degree relatives with acute
aortic dissection/rupture, chronic obstructive pulmonary
disorder, or hypertension; or (3) > 5.0 cm.
Several possible surgical options exist for dila-
tion of the proximal thoracic aorta in BAV patients
without significant valve dysfunction (Table 1).
However, because of the intrinsic weakness of the
aortic wall, there is a significant risk for recurrent
dilation [30, 60]. Ring dilation may be present in
the majority of regurgitant BAVs, and may be in-
dependent or in combination with aortic root di-
lation. If root dilation was present, an annular re-
inforcement was performed using aortic valve re-
implantation technique. After resection of the
aortic sinuses, the aortic valve annulus and sub-
commissural triangles of the non-coronary cusp
were implanted inside a vascular graft [23]. Over-
all survival was not statistically significantly dif-
ferent between the groups, 80 ± 18% in the BAV
group, and 94 ± 3.2% in tricuspid aortic valve
patients [5]. Schäfers et al. [80] recommended
a root diameter of > 4–4.5 cm, depending on the
body surface area of the patient, as a cutoff in
favour of root replacement. They found that free-
dom from reoperation at 5 and 10 years was 95%;
and freedom from valve replacement was 97%,
and suggested that valve preservation for the com-
bination of regurgitant BAV and root dilation were
similar to composite replacement.
Table 1. The surgical strategies for bicuspid aortic valve and the clinical outcomes [6, 7, 17, 29, 58, 65, 70, 97]
Surgical strategy Clinical outcome
Aortic root replacement:
∑ Modified Bentall–DeBono approach with reimplantation Excellent long-term results
of the coronary arteries
∑ Ross operation
∑ Isolated ascending aorta replacement
Aortic root remodelling:
∑ Reduction aortoplasty
∑ Patch augmentation of the incompetent bicuspid aortic valve No re-operations, progression of aortic root dilation
∑ Modified David type repair or recurrent regurgitation occurred. Excellent mid-term
results at a mean follow-up of 5.1 years
Aortic valve replacement:
∑ Reimplantation of the aortic valve
∑ Transcatheter aortic valve implantation Good results in selected patients who were not indicated
for routine aortic valve replacement
Aortic valve repair:
∑ Free edge plication
∑ Subcommissural annuloplasty (obtain a good coaptation
of the aortic valve leaflets)
∑ Mid-leaflet plication of the prolapsing leaflet Freedom from reoperation was 95, 87, and 84% at 1, 5, and
7 years, respectively
∑ Triangular resection of the prolapsing leaflet
∑ Triangular resection of a median raphe
∑ Tricuspidisation cusp extension
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BAV morphology is of prognostic importance.
The raphe of a BAV and less tendency to deposit
calcium are important causes of pure aortic regur-
gitation. Aortic regurgitation was more severe in
the A-P type than in the R-L type BAVs, while aortic
stenosis was more severe in the R-L type than in
the A-P type. Annular dilation was associated with
aortic regurgitation more than aortic stenosis. Su-
pra-annular type prosthetic valve was more fre-
quently inserted in BAV than in non-BAV. The more
diffuse distribution of calcium in BAVs may pre-
clude it from percutaneous valvuloplasty. Valve re-
pair by coapting sutures alone or in combination
with triangular resection of a median raphe with
aortic root remodelling and the ascending aorta
and proximal arch replacement can obtain promis-
ing outcomes. Coaption line of the tricuspid aortic
valve and a prominent raphe giving an appearance
of an additional coaption line may lead to a false
negative result [25].
In patients with a regurgitant BAV and dila-
tion of the proximal aorta > 5 cm, valve repair of
BAVs by using coapting sutures alone or in com-
bination with triangular resection of a median
raphe, along with aortic root remodelling and as-
cending aorta and proximal arch replacement, pro-
vided promising outcomes [58]. Tricuspidisation
cusp extension and the Ross procedure were indi-
cated for paediatrics [58, 70]. During aortic valve
repair for ascending aortic aneurysms, preserving
functionally normal BAVs may bring about a low
perioperative risk with encouraging early results
[93]. Zalaquett et al. [103] reported a triangular
resection of the prolapsing larger cusp including
the median raphe performed in 17 cases, 13 of
which had a regurgitant BAV undergoing a com-
plementary subcommissural annuloplasty. There
were no deaths during the follow-up period. Re-
operation-free rates were 93% ± 6.4% at 1 year
and 85% ± 9.5% at 5 years. Kin et al. [49] ob-
tained similar results in BAV patients with aortic
regurgitation for aortic valve repair. The 5-year
survival rate was 90 ± 7%. The 1- and 5-year re-
operation-free rates were 87 ± 12% and 76 ± 23%,
respectively. But patients with a BAV and a history
of aortic insufficiency may develop moderate autograft
dysfunction after the Ross procedure during long-term
follow-up [31].
In conclusion, BAV is the most common congen-
ital heart disease, which is not a disorder confined
to the aortic valve, but a spectrum involving the
aortic valve, aortic annulus, aortic root, ascending
aorta, and the left ventricular outflow tract. The dif-
ferent types of BAVs may present with distinct aetio-
logies and morphologies. Apart from b-blockers
and antibacterial therapies, aggressive surgical in-
terventions including aortic root and aortic valve
repair or replacement may bring about excellent clini-
cal outcomes. The anatomopathological features of
BAV may have important implications in decision-
making regarding the surgical treatment of this aor-
tic disorder entity.
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